FDA 483 - Tejinder Glamour, M.D. - June 17, 2025

Tejinder Glamour, M.D., a clinical investigator in Pinellas Park, FL, was cited for significant deficiencies during an FDA inspection. Observations included failures to conduct investigations according to plan, promptly report serious adverse events to the sponsor, and maintain adequate case histories. These issues indicate a lack of adherence to clinical trial protocols and regulatory requirements.